Synthetic biology platform technologies for antimicrobial applications
Author(s)
Braff, Dana; Shis, David Liu; Collins, James J.
DownloadSynthetic Biology Platform Technologies for Antimicrobial Applications-Collins.pdf (588.8Kb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
The growing prevalence of antibiotic resistance calls for new approaches in the development of antimicrobial therapeutics. Likewise, improved diagnostic measures are essential in guiding the application of targeted therapies and preventing the evolution of therapeutic resistance. Discovery platforms are also needed to form new treatment strategies and identify novel antimicrobial agents. By applying engineering principles to molecular biology, synthetic biologists have developed platforms that improve upon, supplement, and will perhaps supplant traditional broad-spectrum antibiotics. Efforts in engineering bacteriophages and synthetic probiotics demonstrate targeted antimicrobial approaches that can be fine-tuned using synthetic biology-derived principles. Further, the development of paper-based, cell-free expression systems holds promise in promoting the clinical translation of molecular biology tools for diagnostic purposes. In this review, we highlight emerging synthetic biology platform technologies that are geared toward the generation of new antimicrobial therapies, diagnostics, and discovery channels.
Date issued
2016-04Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science; Massachusetts Institute of Technology. Synthetic Biology Center; Harvard University--MIT Division of Health Sciences and Technology; Massachusetts Institute of Technology. Department of Biological EngineeringJournal
Advanced Drug Delivery Reviews
Publisher
Elsevier
Citation
Braff, Dana et al. “Synthetic Biology Platform Technologies for Antimicrobial Applications.” Advanced Drug Delivery Reviews 105 (October 2016): 35–43 © 2016 Elsevier B.V.
Version: Author's final manuscript
ISSN
0169-409X